Article Menu
Need Help?
No Article Versions Notes Found
Cite
Mackay, H.J.; Provencheur, D.; Heywood, M.; Tu, D.; Eisenhauer, E.A.; Oza, A.M.; Meyer, R. Phase II/III Study of Intraperitoneal Chemotherapy after Neoadjuvant Chemotherapy for Ovarian Cancer: NCIC CTG OV.21. Curr. Oncol. 2011, 18, 84-90. https://doi.org/10.3747/co.v18i2.725
Mackay HJ, Provencheur D, Heywood M, Tu D, Eisenhauer EA, Oza AM, Meyer R. Phase II/III Study of Intraperitoneal Chemotherapy after Neoadjuvant Chemotherapy for Ovarian Cancer: NCIC CTG OV.21. Current Oncology. 2011; 18(2):84-90. https://doi.org/10.3747/co.v18i2.725
Chicago/Turabian StyleMackay, Helen J., D. Provencheur, M. Heywood, D. Tu, E.A. Eisenhauer, A.M. Oza, and R. Meyer. 2011. "Phase II/III Study of Intraperitoneal Chemotherapy after Neoadjuvant Chemotherapy for Ovarian Cancer: NCIC CTG OV.21" Current Oncology 18, no. 2: 84-90. https://doi.org/10.3747/co.v18i2.725
APA StyleMackay, H. J., Provencheur, D., Heywood, M., Tu, D., Eisenhauer, E. A., Oza, A. M., & Meyer, R. (2011). Phase II/III Study of Intraperitoneal Chemotherapy after Neoadjuvant Chemotherapy for Ovarian Cancer: NCIC CTG OV.21. Current Oncology, 18(2), 84-90. https://doi.org/10.3747/co.v18i2.725
